MedTrace Logo

Chinese Medicine Treat for Hypertensive Renal Injury

NCT04078711 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 520

Last updated 2019-09-06

No results posted yet for this study

Summary

This study evaluates whether the traditional chinese medicine (Qianyangyuyin formula) could prevent and treat early renal injury in patients with hypertension and microalbuminuria (defined as a urinary albumin to creatinine ratio between 30 and 300 mg/g) based on standard antihypertensive treatment.

Conditions

Interventions

DRUG

Losartan 100Mg Tab

100Mg Tab, qd, po, 6 months

DRUG

Qianyangyuyin 20g Granule

20g, Granule, bid, po, 6 months

DRUG

placebo

Similar granule manufactured to mimic qianyangyuyin granule, 20g, Granule, bid, po, 6 months

Sponsors & Collaborators

  • Ministry of Science and Technology of the People´s Republic of China

    collaborator OTHER_GOV

  • Affiliated Hospital of Liaoning University of Traditional Chinese Medicine

    collaborator OTHER

  • The First Affiliated Hospital of Henan University of Traditional Chinese Medicine

    collaborator OTHER

  • Jiangsu Province Hospital of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • Zhuyuan Fang · Jiangsu Province Hospital of Traditional Chinese Medicine

  • Ming Liu · Jiangsu Province Hospital of Traditional Chinese Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-10
Primary Completion
2021-06-30
Completion
2021-12-30

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04078711 on ClinicalTrials.gov